For thrombocytopenia in the hospitalized patient
Trajectory earns escalation. Non-progression earns release.
1. How this module fits in Consult Practice
| Lens | What it contributes here |
|---|---|
| Orientation | Defines what kind of danger is plausible |
| Thinking | Assigns and revises weight within that danger |
| Execution | Translates posture shifts into visible action and communication |
2. What this module is for
To help clinicians answer:
“What new data would change how I weight or communicate the platelet abnormality?”
3. How to use this module
Revisit this module as counts and clinical state evolve.
4. Why this matters
Consultants revise concern deliberately as biology declares itself.
Release by non-progression is as important as escalation.
5. Core Content
| Finding | Posture shift | Execution implication |
|---|---|---|
| Rapid platelet decline | escalate concern | broaden vigilance and communication |
| Stable or improving count | release urgency | communicate restraint and reduced tempo |
| Bleeding develops | shift toward hemorrhagic-risk terrain | prioritize protection and hemostatic planning |
| Thrombosis develops | shift toward thrombotic terrain | reassess stance and competing-harms posture |
| Smear shows clumping only | suggests spurious signal | avoid unnecessary escalation and reframe urgency |
| Smear shows fragmentation or abnormal platelets | increases high-risk weighting | escalate vigilance and communicate higher danger |
| No progression over 48–72 hours | release provisional high-risk weighting | narrow surveillance and reduce escalation language |
Key reminder:
Trajectory outranks magnitude. Escalate or release based on how the story evolves, not on what the number is.
6. Bottom line
Use this module to guide safe stance revision and communication.